Skip to search formSkip to main contentSkip to account menu

Carboplatin/Etoposide/Melphalan Regimen

Known as: CEM, CEM Regimen 
A regimen containing carboplatin, etoposide and melphalan used for the treatment of childhood neuroblastoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
The human leukemia cell lines K562, CEM, CEM/VLB(100), human leukemic blasts, and the bladder cancer J82 cell line have different… 
Highly Cited
2001
Highly Cited
2001
Thioguanine and mercaptopurine are prodrugs requiring conversion into thiopurine nucleotides to exert cytotoxicity. Thiopurine S… 
Review
2000
Review
2000
Purpose and methods: The lack of a functional DNA mismatch repair (MMR) pathway has been recognized as a common characteristic of… 
Highly Cited
1999
Highly Cited
1999
It has been suggested that the ratio of Bcl-2 family proapoptotic proteins to antiapoptotic proteins determines the sensitivity… 
Highly Cited
1994
Highly Cited
1994
The viral infectivity factor gene vif of human immunodeficiency virus type 1 (HIV-1) has been shown to enhance the cell-free… 
Highly Cited
1991
Highly Cited
1991
The V3 loop (residues 303-338) of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope protein represents a principal… 
Highly Cited
1983
Highly Cited
1983
Methotrexate (MTX)-resistant sublines of malignant human cells were selected in vitro by stepwise increase in drug concentration… 
Highly Cited
1979